Cite

MLA Citation

    Daniel Steffens et al.. “PCSK9 inhibitors and cardiovascular outcomes.” Expert opinion on biological therapy, vol. 20, 2020, pp. 35–47. http://access.bl.uk/ark:/81055/vdc_100098063367.0x000013
  
Back to record